Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report
DOI:
https://doi.org/10.31729/jnma.6454Keywords:
bundle-branch block, case report, COVID-19 vaccine, NepalAbstract
Nepal started the COVID-19 vaccination on 27 January 2021 with AstraZeneca/Oxford Coronavirus Disease-19 AZD1222 (Covishield) vaccine to control the Coronavirus disease pandemic. The vaccine has a good safety profile, with cardiovascular complications being rare. Herein we report a rare case of cardiovascular complication following Covishield vaccination in a 33 years old female who had dizziness and elevated blood pressure immediately following vaccination and abnormal electrocardiogram showing T wave inversions followed by left bundle branch block. The patient was kept on observation, following which the blood pressure and electrocardiogram changes were normal by seven days. This cardiovascular complication following the vaccination demands further investigation into the adverse event of the vaccine. However, since the benefit of the vaccine outweighs the risk, World Health Organization has recommended the continuity of the vaccine as of now.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Angela Basnet, Shiva Kumar Ojha, Suman Kumar Jha, Anjana Paudyal, Manoj Khadka, Manita Khadka, Dhan Bahadur Shrestha

This work is licensed under a Creative Commons Attribution 4.0 International License.
JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.